Provided by Tiger Fintech (Singapore) Pte. Ltd.

Keros Therapeutics, Inc.

14.44
-0.0100-0.07%
Post-market: 14.04-0.3890-2.70%19:10 EDT
Volume:746.63K
Turnover:10.77M
Market Cap:585.72M
PE:-2.89
High:14.60
Open:14.40
Low:14.27
Close:14.45
Loading ...

Keros Therapeutics, Takeda in Elritercept Licensing Pact

Dow Jones
·
03 Dec 2024

Keros Therapeutics Enters Global Development, License Deal with Takeda Pharmaceutical for Elritercept

MT Newswires Live
·
03 Dec 2024

Takeda, Keros Therapeutics enter exclusive elritercept license agreement

TIPRANKS
·
03 Dec 2024

BRIEF-Takeda Strengthens Oncology Pipeline With Elritercept Through Licensing Agreement With Keros Therapeutics

Reuters
·
03 Dec 2024

Keros Therapeutics Inc Says Co to Receive Upfront Payment of $200 Mln

THOMSON REUTERS
·
03 Dec 2024

Keros Therapeutics Inc Says Co Eligible to Receive Development, Approval Commercial Milestone Payments With Potential to Exceed $1.1 Bln

THOMSON REUTERS
·
03 Dec 2024

Keros Therapeutics Announces Global License Agreement With Takeda to Advance Elritercept

THOMSON REUTERS
·
03 Dec 2024

Keros Therapeutics Showcases Innovations at Major Conferences

TIPRANKS
·
26 Nov 2024

Keros Therapeutics Announces Participation at Upcoming Healthcare Conferences

GlobeNewswire
·
26 Nov 2024

BUZZ-Cautious uptake of Merck's Winrevair gives opportunity to rivals, Oppenheimer says

Reuters
·
14 Nov 2024

Keros Therapeutics Third Quarter 2024 Earnings: US$1.41 loss per share (vs US$1.33 loss in 3Q 2023)

Simply Wall St.
·
08 Nov 2024

BRIEF-Keros Therapeutics Q3 EPS USD -1.41

Reuters
·
07 Nov 2024

Keros Therapeutics Q3 Net Income USD -52.956 Million

THOMSON REUTERS
·
07 Nov 2024

Keros Therapeutics Reports Recent Business Highlights and Third Quarter 2024 Financial Results

GlobeNewswire
·
07 Nov 2024

Keros Therapeutics Inc expected to post a loss of $1.28 a share - Earnings Preview

Reuters
·
06 Nov 2024

Jefferies starts Keros with Buy, sees potential $2B in peak sales

TIPRANKS
·
06 Nov 2024

Keros Therapeutics initiated with a Buy at Jefferies

TIPRANKS
·
06 Nov 2024

Keros Therapeutics to Present at the 66th American Society of Hematology Annual Meeting and Exposition

GlobeNewswire
·
05 Nov 2024